MARATTO

article · Ethiopian Medical Journal

Subarachnoid haemorrhage in a newly diagnosed Chronic Myelogenous Leukemia patient: A diagnostic challenge

20241 citationOpen accessAddis Ababa University

Abstract

Chronic Myelogenous Leukemia (CML) is a myeloproliferative neoplasm with a prevalence of 1 to 2 cases per 100,000 adult population. In chronic myelogenous leukemia (CML), central nervous system (CNS) manifestations are reported in the advanced phase of the disease due to leukostasis, thrombosis, bleeding, infection, and CNS infiltration. However, CNS manifestations are uncommon in the chronic phase (CP) of CML, and an alternate diagnosis should be considered for symptomatic patients. We report a ruptured aneurysmal subarachnoid hemorrhage (SAH) as an initial presentation in a previously undetected CML patient.

Research topics

  • Chronic Myeloid Leukemia Treatments
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Macrophage Migration Inhibitory Factor

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.4314/emj.v62i2.7

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.